This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Short-term IV 24-hour levodopa infusion has been shown to improve motor variability and dyskinesias in patients with Parkinson disease (PD) with motor fluctuations.1 Longer-term around-the-clock enteral infusion of levodopa (n = 1) showed declining motor performance although the infusion rate was rapidly increased.2 It has been proposed that tolerance develops as a result of long continuous infusions of levodopa and dopamine agonists.3 Nighttime-only levodopa infusion has been reported in one case with immediate improvement of nocturnal akinesia.4 Duodenal/jejunal levodopa/carbidopa infusion (Duodopa) has evolved into a treatment alternative in patients with advanced PD.5 It is recommended for daytime use partly because of convenience for the patient and partly because of fear of tolerance development. Because nighttime disability and sleep disturbance are common problems for patients with advanced PD,6 oral dopaminergic medication is sometimes used during nighttime to improve sleep. We report retrospective data on five cases with continuous …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
- Long-term 24-hour duodenal infusion of levodopa: Outcome and dose requirements
- Reply from the Authors
- Long-term 24-hour duodenal infusion of levodopa: Outcome and dose requirements
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
